In contrast, patients with T1DM often benefit from insulin therapy regarding neuropathic outcomes, as they typically do not exhibit significant insulin resistance.340 Understanding the role of insulin signaling and insulin resistance in peripheral nerves is essential for developing targeted therapies for DPN. This evidence concerns the gene INS and Insulin resistance.